Virtual Reality Training for Laparoscopic Cholecystectomy
The Impact of 3D Virtual Reality MRCP Rendering on Surgical Performance During Laparoscopic Cholecystectomy: A Pilot Study
1 other identifier
interventional
20
1 country
1
Brief Summary
Cholecystectomy is one the most frequent laparoscopic procedures worldwide. It is a safe and effective operation but intraoperative bile duct injury remains a relevant complication with serious consequences for the patient. Most of the complications occur due to a lack of knowledge of the anatomy or misidentification of the cystic duct. Thus, the study of the anatomy is a cornerstone of a successful procedure and the preoperative magnetic resonance cholangiopancreatography (MRCP) is a way to preoperatively determine relevant structures to avoid intraoperative incidents. This trial has been designed to assess the effect of preoperative virtual reality training based on MRCP on intraoperative performance and outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 7, 2021
CompletedFirst Posted
Study publicly available on registry
December 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedApril 15, 2025
April 1, 2025
4.2 years
December 7, 2021
April 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Global Assessment of Laparoscopic Skills (GOALS) score assessed by assisting surgeon
For the global assessment of laparoscopic skills, the Global Operative Assessment of Laparoscopic Skills (GOALS) will be used. Evaluation will be performed by the attending surgeon. The GOALS is a 5 item rating scale and the items are scored using a 5-point Likert scale where "1" represents the lowest level of performance, and "5" is considered ideal performance. The total score for the global rating scale is the sum of the scores for each of the 5 items for a maximum total score of 25.
On the day of surgery (within 12 hours)
Secondary Outcomes (7)
Global Assessment of Laparoscopic Skills (GOALS) score assessed by resident
On the day of surgery (within 12 hours)
Critical View of Safety
Postoperative within 30 days (Video-Analysis)
Time to critical view of safety
Postoperative within 30 days (Video-Analysis)
Efficiency improvement
On the day of surgery (within 12 hours)
Self-confidence
On the day of surgery (within 12 hours)
- +2 more secondary outcomes
Other Outcomes (2)
Length of hospital stay
At the day of discharge
90-day postoperative Complications
Until 90 days after surgery
Study Arms (2)
Virtual Reality MRCP
EXPERIMENTALThe MRCP images will be transferred into a 3D VR rendering software (Specto VR TM) for each patient. Residents will have the opportunity to use the virtual reality environment the day before surgery until a sufficient understanding of the anatomy is achieved.
Conventional MRCP
ACTIVE COMPARATORControls will have regular access to the conventional MRCP images.
Interventions
In the Virtual Reality (VR) study arm, a VR software (Specto VRTM, version 4.0, Diffuse Ltd, Heimberg, Switzerland) will be used to display volumetric MRCP data using a tethered head-mounted display (HMD) prior to the operation. Specto uses volume rendering at 180 frames/sec to visualize the medical data in an immersive fashion in the VR environment and allows for viewing of the 3D reconstructed 3D imaging with 360° free movement. Each participant will perform a procedure with VR training and one with conventional preparation (MRCP).
In the conventional study arm, the participants will view the preoperative MRCP.
Eligibility Criteria
You may qualify if:
- Referred for elective cholecystectomy for symptomatic cholecystolithiasis/chronic cholecystitis
- Early cholecystectomy after acute biliary pancreatitis
- Concomitant minor procedures (adhesiolysis, umbilical hernia repair, liver biopsy)
- Sufficient quality of MRCP
You may not qualify if:
- American Society of Anaesthesiologists (ASA) classification ≥ 4
- Previous major open upper abdominal surgery
- Suspicion for concomitant biliary disease (e.g. Mirizzi-Syndrome)
- Robotic cholecystectomy
- Planned open procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- University of Baselcollaborator
Study Sites (1)
University Centre for Gastrointesintal and Liver Disease
Basel, 4058, Switzerland
Related Publications (4)
Nassar AHM, Ashkar KA, Mohamed AY, Hafiz AA. Is laparoscopic cholecystectomy possible without video technology? Minimally Invasive Therapy. 1995; 4:2 63-65
BACKGROUNDVassiliou MC, Feldman LS, Andrew CG, Bergman S, Leffondre K, Stanbridge D, Fried GM. A global assessment tool for evaluation of intraoperative laparoscopic skills. Am J Surg. 2005 Jul;190(1):107-13. doi: 10.1016/j.amjsurg.2005.04.004.
PMID: 15972181BACKGROUNDSanford DE, Strasberg SM. A simple effective method for generation of a permanent record of the Critical View of Safety during laparoscopic cholecystectomy by intraoperative "doublet" photography. J Am Coll Surg. 2014 Feb;218(2):170-8. doi: 10.1016/j.jamcollsurg.2013.11.003. Epub 2013 Nov 9.
PMID: 24440064BACKGROUNDGeoffrion R, Lee T, Singer J. Validating a self-confidence scale for surgical trainees. J Obstet Gynaecol Can. 2013 Apr;35(4):355-361. doi: 10.1016/S1701-2163(15)30964-6.
PMID: 23660044BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian Staubli, MD
Clarunis - University Center for Gastrointestinal and Liver Diseases
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes Assessor and analyst
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2021
First Posted
December 23, 2021
Study Start
November 1, 2021
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share